Immunotherapy in advanced cutaneous squamous cell carcinoma: Sydney west cancer network experience.
Shaheen HasmatJulie R HowleMatteo S CarlinoPuma SundaresanMichael J VenessPublished in: ANZ journal of surgery (2022)
This study confirms the clinical efficacy of cemiplimab in patients with advanced CSCC with many experiencing a durable response and an acceptable adverse effect profile.